"We are already doing preclinical studies on a vaccine against AIDS, we at the second phase of pre-clinical studies," — said Uiba, transfers
"The likelihood is that this vaccine will reach clinical trials and will be effective, very high, today, this vaccine has 100% exposure to the clinical effect," — said Uiba.
"Nano vaccines against HIV infection entirely new generation, as Russian scientists took RNA pathogen," — said Uiba.
All existing vaccines now used himself alive or "killed" virus.
"In all three vaccines has very high efficiency even at the stage of pre-clinical studies," — said the head of the FMBA.
According to him, prior to the stage of clinical trials will be held for two years.
Recall that in February 2010 the FMBA